This 75-hour on-demand conference includes 64 sessions highlighting best practices and the latest science, research, and innovations in addiction medicine from leading experts in the field.

This 75-minute on-demand session from the ASAM 56th Annual Conference addresses the prevalence and risks of alcohol use during pregnancy, management of acute withdrawal, and evidence-based treatment strategies for alcohol use disorder in the perinatal period.

This 60-minute on-demand session from the ASAM 56th Annual Conference addresses strategies and system-level changes to better engage the 95% of individuals with substance use disorders who are not currently accessing or interested in services.

This 75-minute on-demand session from the ASAM 56th Annual Conference addresses emerging substances of misuse and their impact on pregnancy, with guidance on harm reduction, clinical care, and counseling in the context of evolving cannabis and CBD use.

This 75-minute on-demand session from the ASAM 56th Annual Conference addresses principles of low-threshold care, the collaboration between medical and harm reduction specialists, and evidence-based interventions adapted for harm reduction settings.

This 45-minute on-demand session from the ASAM 56th Annual Conference addresses integrating harm reduction, reducing stigma, and the role of interprofessional teams with lived experience in providing person-centered addiction care in the hospital.

This 75-minute on-demand session from the ASAM 56th Annual Conference addresses the "Simplified Approach to HCV Treatment" recommended in the national HCV guidelines, focusing on how it may be implemented outside of traditional primary care and specialty care clinic settings and highlighting the patient voice and the perspective of persons with lived experience on the relationship between HCV treatment, substance use, and general health.

This 75-minute on-demand session from the ASAM 56th Annual Conference focuses sexualized drug use, such as the use of gamma-hydroxybutyrate (GHB), methamphetamine, or mephedrone, and provides an overview of harm reduction, assessment and treatment considerations for effectively addressing substance use in the LGBTQ population, through a case-based educational experience.

This 75-minute on-demand session from the ASAM 56th Annual Conference addresses SAMHSA's principles of low barrier care, the importance of local context in clinical models, and strategies to reduce barriers in your own clinical setting.

This 60-minute on-demand session from the ASAM 56th Annual Conference addresses ethical dilemmas in person-centered substance use disorder treatment and explores harm reduction strategies, emotional resilience, and practical approaches to maintaining patient-centered care in complex cases.